MeSH tree: C12.050
Polycystic ovary syndrome (PCOS) has been renamed polyendocrine metabolic ovarian syndrome (PMOS). Professor Helena Teede led this name change after 14 years of research and global collaboration. But why was it needed?
32 minutes ago
0
0
The association between parents' body mass index (BMI) and their children's childhood BMI may be primarily due to genetic inheritance rather than any direct biological effect of parental weight during pregnancy, according ...
2 hours ago
0
0
Managing a medical supply chain in low- and middle-income countries can mean navigating a landscape prone to extreme and unexpected disruptions. In Sierra Leone, for instance, external forces ranging from an attempted military ...
3 hours ago
0
0
Pregnant women with a severe form of nausea face increased risks for several pregnancy and birth complications, according to a new Stanford Medicine study of 2.5 million California births.
9 hours ago
0
3
A target trial emulation study found that among women with cervical intraepithelial neoplasia (CIN) grade 2 (CIN 2), a moderate form of precancerous cervical dysplasia, excision within six months did not lower three-year ...
23 hours ago
0
1
A new study from the Icahn School of Medicine at Mount Sinai shows that social determinants of health—including environmental conditions, health behaviors, access to resources and social well-being—can play an equally important ...
Jun 22, 2026
0
6
A study conducted at the University of Oulu and Oulu University Hospital suggests that factors related to maternal weight are reflected in signaling particles produced by the maternal microbiota not only in the gut but also ...
Jun 21, 2026
0
4
Nearly half of Americans with kidney failure who are referred for transplantation never begin the process required to be considered for a new organ, a new study shows, while less than a fifth actually complete the assessment ...
Jun 20, 2026
1
27
A coronial inquest is this week examining the death of Melbourne wellness influencer Stacey Warnecke after a freebirth at her home in September.
Jun 19, 2026
0
5
The U.S. Food and Drug Administration has approved Merck's Welireg (belzutifan) in combination with pembrolizumab or pembrolizumab and berahyaluronidase alfa-pmph (Keytruda Qlex) for the adjuvant treatment of renal cell carcinoma ...
Jun 19, 2026
0
6
